68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label PET/CT (positron emission tomography/computed tomography) study to
investigate the diagnostic performance of 68Ga-BNOTA-PRGD2 in evaluation of myocardial
infarction. A single dose of nearly 111 MBq 68Ga-BNOTA-PRGD2 ( ≤ 40 µg BNOTA-PRGD2) will be
intravenously injected into myocardial infarction patients. Visual and semiquantitative
method will be used to assess the 68Ga-BNOTA-PRGD2 PET/CT cardiac images and compared to the
99mTc-MIBI SPECT myocardial perfusion images and the 18F-FDG metabolism images.